Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Utility of electrochemotherapy in melanoma treatment.
Testori A, Rossi CR, Tosti G.
Curr Opin Oncol. 2012 Mar;24(2):155-61. Review.
Related citations
Ocular melanoma: what's new?
Leyvraz S, Keilholz U.
Curr Opin Oncol. 2012 Mar;24(2):162-9. Review.
Is ulceration in cutaneous melanoma just a prognostic and predictive factor or is ulcerated melanoma a distinct biologic entity?
Eggermont AM, Spatz A, Lazar V, Robert C.
Curr Opin Oncol. 2012 Mar;24(2):137-40. Review.
Epidemiological evidence that UVA radiation is involved in the genesis of cutaneous melanoma.
Autier P, Doré JF, Eggermont AM, Coebergh JW.
Curr Opin Oncol. 2011 Mar;23(2):189-96. Review.
Immunotherapy for melanoma.
Weber J.
Curr Opin Oncol. 2011 Mar;23(2):163-9. Review.
Autoimmunity and treatment outcome in melanoma.
Bouwhuis MG, Ten Hagen TL, Suciu S, Eggermont AM.
Curr Opin Oncol. 2011 Mar;23(2):170-6. Review.
Isolated limb perfusion for melanoma in-transit metastases: developments in recent years and the role of tumor necrosis factor alpha.
Deroose JP, Eggermont AM, van Geel AN, Verhoef C.
Curr Opin Oncol. 2011 Mar;23(2):183-8. Review.
Mutation-driven drug development in melanoma.
Flaherty KT, Hodi FS, Bastian BC.
Curr Opin Oncol. 2010 May;22(3):178-83. Review.
Current world literature.
[No authors listed]
Curr Opin Oncol. 2010 May;22(3):281-99. No abstract available.
The biology behind prognostic factors of cutaneous melanoma.
Spatz A, Batist G, Eggermont AM.
Curr Opin Oncol. 2010 May;22(3):163-8. Review.
New developments in sentinel node staging in melanoma: controversies and alternatives.
van Akkooi AC, Voit CA, Verhoef C, Eggermont AM.
Curr Opin Oncol. 2010 May;22(3):169-77. Review.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on